The University of Illinois Cancer Center, in collaboration with the American Cancer Society and Genentech, is hosting a UNITY Summit featuring a panel of leading national cancer experts discussing equity in precision prevention oncology.
The event will take place May 31 at Reggie’s Chicago from 2-6 p.m.
Panel members will discuss precision prevention approaches and how to personalize prevention, screening, treatment and survivorship care for patients based on biological vulnerabilities, behaviors and broader social determinants of health (SDOH).
UNITY Summit Registration HERE
The discussion will be moderated by Cancer Center Associate Director for Community Outreach and Engagement Yamile Molina, PhD. In addition to their work at the Cancer, they are Associate Director for Community Engaged Research at UI Health Mile Square Health Center, a federally qualified health center (FQHC), and an Associate Professor in the Division of Community Health Sciences at the University of Illinois Chicago (UIC) School of Public Health.
Summit Panelists
Julie R. Gralow, MD, FACP, FASCO, is the Chief Medical Officer and Executive Vice President of ASCO and brings to her role deep expertise in patient care, research, education and global health.
VK Gadi, MD, PhD, is Cancer Center Deputy Director and a UI Health Medical Oncologist. As an academic investigator, he develops and conducts clinical trials of new medicines, diagnostic tools and supportive care to improve outcomes for patients with breast cancer or other types of cancers.
Melissa B. Davis, PhD, is the newly appointed Director of the Institute of Translational Genomic Medicine at Morehouse School of Medicine. She also serves as Scientific Director of the International Center for the Study of Breast Cancer Subtypes (ICSBCS), (Interim) Director of Health Equity for the Englander Institute of Precision Medicine and Associate Professor of Cell and Developmental Biology in the Department of Surgery and at Weill Cornell Medicine in New York, NY.
Clayton Yates, PhD, is recognized for his international expertise in addressing cancers with African Ancestry and is currently appointed as the John R. Lewis Professor of Pathology, Oncology, and Urology and Director of Health Disparities and Global Health Equity at Johns Hopkins School of Medicine.
Katherine Y. Tossas, PhD, MS, is an assistant professor at Virginia Commonwealth University School of Population Health, as well as founding director at VCU Massey Comprehensive Cancer Center’s Office of Catchment Area Data Alignment.
Natalie Reizine, MD, is a Cancer Center member and assistant professor and clinical investigator at the University of Illinois College of Medicine Chicago, with an academic focus on genitourinary cancers. She is also a physician and researcher in the Division of Hematology and Oncology at UI Health.
Electra Paskett, PhD, is the Marion N. Rowley Professor of Cancer Research at The Ohio State University, Director of the Division of Cancer Prevention and Control in the College of Medicine, a professor in the Division of Epidemiology in the College of Public Health and the Deputy Director for Population Sciences and Community Outreach in the Comprehensive Cancer Center of the Ohio State University and Founding Director of the Center for Cancer Health Equity in the James Cancer Hospital.
Ruben A. Mesa, MD, FACP, is the president and executive director of Atrium Health Levine Cancer, vice dean for cancer programs and professor of medicine at Wake Forest University School of Medicine.
Larry Kessler, ScD, is professor in the Department of Health Systems and Population Health at the University of Washington School of Public Health. He also serves as Deputy Chair of the Multi-Cancer Early Detection Consortium.
Pamela Ganschow, MD, is the Cancer Center Director for Cancer Prevention and Survivorship Clinical Programs. Her cancer-relevant research interests span the breadth of cancer care, from screening and prevention through diagnosis and survivorship, identifying gaps and developing best practices in cancer care across the continuum.